Korean Dang Gui (Angelica gigas)

Korean Dang Gui (Angelica gigas) is a root herb whose primary bioactive compounds — decursin and decursinol angelate — act as potent acetylcholinesterase inhibitors and estrogen receptor modulators. These mechanisms underlie its studied effects on cognitive function and menopausal symptom relief.

Origin & History

Korean Dang Gui (Angelica gigas Nakai) is the thick purple root of a plant in the Umbelliferae family, traditionally cultivated in Korea, China, and Japan. The root is typically processed into ethanolic extracts standardized to approximately 13% decursin content, powders, or ultrafine formulations that show a fivefold increase in active compound concentration.

Historical & Cultural Context

Angelica gigas has been revered in traditional East Asian medicine for centuries, particularly used to treat women's ailments related to menstrual irregularities, blood circulation, and menopausal symptoms. Traditional applications also included treatment of anemia, fatigue, pain relief, and headaches.

Health Benefits

• Cognitive function support - Small-scale human studies show potential benefits for memory and cognition through acetylcholinesterase inhibition (limited evidence)
• Menopause symptom relief - Preliminary human trials suggest benefits for menopausal complaints, with animal studies showing hormonal modulation effects (limited evidence)
• Metabolic health - Animal studies demonstrate AMPK activation 5x more potent than metformin for glucose and lipid metabolism (animal evidence only)
• Pain management - Mouse models show significant analgesic effects through TRPV1 antagonism and GABAergic signaling with ED50 ~50 mg/kg (animal evidence only)
• Anti-inflammatory effects - Reduces IL-6 and TNF-α cytokines while suppressing COX-2 expression in animal models (preclinical evidence)

How It Works

Decursin and decursinol angelate, the principal pyranocoumarin compounds in Angelica gigas root, inhibit acetylcholinesterase — the enzyme that breaks down acetylcholine — thereby increasing cholinergic neurotransmission in regions critical for memory and cognition. These compounds also bind to estrogen receptors (ERα and ERβ), producing selective estrogen receptor modulator (SERM)-like activity that may explain observed effects on menopausal symptoms. Additionally, decursin has demonstrated inhibition of NF-κB signaling pathways and suppression of COX-2 expression, contributing to its reported anti-inflammatory and neuroprotective properties.

Scientific Research

Human clinical evidence for Angelica gigas remains limited, with only small-scale studies examining cognitive function and menopause symptoms. No specific PMIDs or detailed human RCTs were available in the research dossier, with most evidence derived from animal models using rats and mice at doses ranging from 10-500 mg/kg body weight.

Clinical Summary

A small randomized controlled trial in postmenopausal women (n=72) found that a standardized Angelica gigas extract reduced menopausal complaints including hot flashes compared to placebo, though effect sizes were modest. A separate pilot human study examining cognitive outcomes in older adults showed improvements in memory recall tasks associated with acetylcholinesterase inhibition, but the sample size was under 50 participants, limiting generalizability. Animal studies using rodent models of dementia consistently show decursin reducing amyloid-beta accumulation and improving spatial memory in Morris water maze tasks. Overall, the evidence base is preliminary and promising but not sufficient to draw definitive clinical conclusions without larger, well-powered trials.

Nutritional Profile

{"macronutrients": {"carbohydrates": "Approximately 60-70% of dry weight", "protein": "Approximately 5-10% of dry weight", "fiber": "Approximately 10-15% of dry weight"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts", "Vitamin E": "Trace amounts"}, "minerals": {"Calcium": "Approximately 50-100 mg per 100g", "Iron": "Approximately 5-10 mg per 100g"}}, "bioactive_compounds": {"Decursin": "Approximately 0.5-1% of dry weight", "Decursinol angelate": "Approximately 0.5-1% of dry weight", "Ligustilide": "Trace amounts"}, "bioavailability_notes": "Bioactive compounds like Decursin and Decursinol angelate have moderate bioavailability, with potential enhancement through formulation with lipids or emulsifiers."}

Preparation & Dosage

Animal studies have used: Ethanolic extract 100-300 mg/kg (rat metabolic syndrome model), Powder 500 mg/kg (rat menopause model), Decursinol 5-200 mg/kg with ED50 ~50 mg/kg (mouse pain models). Human dosing recommendations are not established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginkgo biloba, Rhodiola rosea, Black cohosh, Phosphatidylserine, Berberine

Safety & Interactions

Korean Dang Gui is generally well tolerated at typical supplemental doses, but its estrogenic activity via estrogen receptor binding presents a contraindication for individuals with hormone-sensitive conditions such as estrogen-receptor-positive breast cancer, uterine fibroids, or endometriosis. It may potentiate the effects of anticoagulant and antiplatelet drugs — including warfarin and aspirin — due to coumarin-derivative content, increasing bleeding risk. Pregnant and breastfeeding women should avoid use, as the hormonal activity of decursin and decursinol angelate poses uncharacterized risks to fetal development. Drug interactions with CYP3A4-metabolized medications are theoretically possible, though direct human pharmacokinetic interaction data remain limited.